SIGNATUREFD, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 151 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$468
-74.2%
3,5500.0%0.00%
Q2 2023$1,811
-19.0%
3,5500.0%0.00%
Q1 2023$2,237
-2.9%
3,5500.0%0.00%
Q4 2022$2,304
-71.2%
3,550
-25.3%
0.00%
Q3 2022$8,000
+100.0%
4,752
+33.9%
0.00%
Q2 2022$4,000
+100.0%
3,5500.0%0.00%
Q1 2022$2,000
-50.0%
3,550
+1.4%
0.00%
Q4 2021$4,000
-89.2%
3,500
-82.8%
0.00%
-100.0%
Q3 2021$37,000
+12.1%
20,325
+64.9%
0.00%0.0%
Q2 2021$33,000
-25.0%
12,3220.0%0.00%
-50.0%
Q1 2021$44,000
+37.5%
12,322
-2.8%
0.00%0.0%
Q4 2020$32,000
+255.6%
12,672
+262.1%
0.00%
Q3 2020$9,000
-30.8%
3,500
-8.5%
0.00%
-100.0%
Q2 2020$13,000
+8.3%
3,825
-19.8%
0.00%0.0%
Q1 2020$12,000
-29.4%
4,772
+36.3%
0.00%0.0%
Q4 2019$17,000
+13.3%
3,5000.0%0.00%0.0%
Q3 2019$15,000
-25.0%
3,5000.0%0.00%
-50.0%
Q2 2019$20,000
+53.8%
3,5000.0%0.00%
+100.0%
Q1 2019$13,000
+85.7%
3,5000.0%0.00%0.0%
Q4 2018$7,000
-36.4%
3,5000.0%0.00%0.0%
Q3 2018$11,0000.0%3,5000.0%0.00%0.0%
Q2 2018$11,000
+37.5%
3,500
+133.3%
0.00%0.0%
Q3 2016$8,0001,5000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders